Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.Researchers plan to recruit 4500 men and women from a random
Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the companys patented electron beam tomography technology.
Researchers plan to recruit 4500 men and women from a random sample of the general population of the Ruhr industrial district in Germany. The study will focus on the direct detection of atherosclerosis instead of on risk factors that predict the probability of the disease.
EBT coronary calcium detection scanning will be compared with other measures of atherosclerosis in other vessels such as the carotid and peripheral arteries.
Imatrons primary product is the EBT scanner, which is now in use at more than 120 imaging facilities around the world.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).